🇺🇸 FDA
Patent

US 6531475

CRF receptor antagonists and methods relating thereto

expired A61PA61P25/22

Quick answer

US patent 6531475 (CRF receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Mar 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61P, A61P25/22